AVDL Avadel Pharmaceuticals (NASDAQ) $21.64 05 Mar 2026: earnings set to guide next move

AVDL stock trades at $21.64 after a quiet market close on 05 Mar 2026, with Avadel Pharmaceuticals plc (AVDL) preparing to report quarterly results on 09 Mar 2026. The narrow intraday range masks heavy volume interest today — 35,016,239.00 shares traded versus an average of 2,415,222.00. Investors will watch revenue cadence, FT218 development updates, and margin commentary. This earnings report is the most likely near-term catalyst to move price and reset expectations for the drug maker listed on NASDAQ in the United States (USD).